traffic analytics Rx&D - Canada's Research Based Pharmaceutical Companies
  Rx&DAbout Rx&DPharmaceutical Community
PublicationsMedia CentreStakeholders & PartnershipsMember's Login
 
 
 
  Forgot Password?
  Account Application
Rx&D HomeFrançaisContact Us
Useful LinksSite Map
  Pharmaceutical Community

Code of Conduct - Question & Answers

13. Advisory Boards - February 2005
 

Question 1:
What are your rules on "consultations"? Does this event conform to your new guidelines?

Last night I attended the first Biovail "consultation". It was basically a sales job for Tiazac XC. I donated the $350 honorarium to McGill University. Then they handed out another invitation (see below). Another "consultation". This time for $400 and our spouses also get to enjoy the 'souper-spectacle' at the Casino for free. I don't know what this show normally costs.

Do you still think this is ethical?

Response:
1. Section 13 of our Code of Conduct prohibits this type of activity.
2. “We urge all companies that market or sell pharmaceuticals, but are not members of Rx&D, to follow this Code also. Because Biovail is a non-member, Rx&D has no empowerment to enforce this Code upon them. The CEO of Biovail, and the President of the Canadian Drug Manufacturers Association should be made aware of this questionable activity.




Revised: June 06, 2005
 
 
Back to top

Home | About Rx&D | Pharmaceutical Community | Publications | Media Centre | Stakeholders & Partnerships
Useful Links | Français | Contact Us | Site Map

55 Metcalfe Street, Suite 1220, Ottawa, Ontario K1P 6L5
Tel.: (613) 236-0455 Reception Fax: (613) 236-6756
Strategic Affairs & Communications Fax: (613) 236-6861
Federal Affairs Fax: (613) 236-7919
© 2007 Rx&D Terms and Conditions of Use
All Rights Reserved